Certification for Hikal's drug

Mumbai: Hikal Ltd has received the Certificate of Suitability (CoS) in Europe for Ondansetron Hydrochloride Dihydrate, used to prevent vomiting during surgery and in cancer-related treatments such as chemotherapy and radiotherapy. The European Directorate for the Quality of Medicines has certified the product after evaluating its dossiers, the company said in a statement. 'We have filled 3 more products for CoS in Europe apart from Ondansetron. This certificate will enable us commercialise our product for European countries', said Mr Jai Hiremath, Vice-Chairman and Managing Director, Hikal Ltd.